Cambridge Pancreatic Cancer Symposium 2022
The programme for the Cambridge Pancreatic Cancer Symposium 2022 is shown below. See below for links to recordings of some talks and slides.
You can read more about the speakers and their talks here, or click on the links in the programme below.
Welcome by Prof Richard Gilbertson, CRUK Cambridge Institute, University of Cambridge
Meeting opening by Dr Bristi Basu
Video: The patient representatives’ view of pancreatic cancer
Video coming soon!
Session 1: Early Detection of Pancreatic Cancer
Chair: Dr Ljiljana Fruk, Department of Chemical Engineering and Biotechnology, University of Cambridge
Dr Pilar Acedo, University College London
Addressing a Key Challenge of Pancreatic Cancer: Early Detection
Prof Fiona Walter, Queen Mary University London
Early detection of pancreatic cancer – a primary care perspective
Panel discussion including Prof Stephen Pereira, University College London
Session 2: The Tumour Microenvironment
Chair: Dr Giulia Biffi, CRUK Cambridge Institute, University of Cambridge
Dr Vincenzo Corbo, University of Verona
Differential activation of MAPK pathway in the stroma of pancreatic cancer subtypes
Dr Ruth Scherz-Shouval, Weizmann Institute, Israel
Stress and mutation dependencies shaping the tumour microenvironment
Prof Michael Schmid, University of Liverpool
Tumour-stroma-immune interactions in pancreatic cancer metastasis
Panel discussion including Prof Jen Morton, CRUK Beatson Institute, University of Glasgow
Session 3: Keynote
Chair: Prof Duncan Jodrell, University of Cambridge
Keynote speaker: Dr Robert H. Vonderheide, Abramson Cancer Center, University of Pennsylvania
Case for priming, not checkpoint, in cancer immunotherapy of pancreas cancer
Poster session
Poster winners:
1st place: Andrés García-Sampedro (UCL, Pereira/Acedo)
Photochemical internalisation to enhance pancreatic cancer chemotherapy
2nd place: Marc Hennequart (Francis Crick Institute, Vousden)
Loss of ALDH1L2 expression and formate overflow as biomarkers for pancreatic cancer detection
Best student poster abstracts:
Vincenzo Graziano (Jodrell), CRUK Cambridge Institute
Eloise Lloyd (Biffi), CRUK Cambridge Institute
Catarina Pelicano (Carroll), CRUK Cambridge Institute
Session 4: New Therapeutic Targets and Treatment
Chair: Dr Bristi Basu, Cambridge University Hospitals
Prof Axel Behrens, Institute of Cancer Research, London
Molecular mechanisms controlling cellular heterogeneity of pancreatic cancer
Dr Rushika Perera, University of California, San Francisco, US
Unravelling autophagy-lysosome dependent adaptations to stress in pancreatic cancer
Dr Silvia Formenti, Weill Cornell, US
Radiation techniques and technology: relevance to immuno-radiotherapy of pancreatic cancer
Panel Discussion including Dr Simon Barry, Astra Zeneca
Meeting close by Dr Giulia Biffi